T
Timothy J Wilt
Researcher at University of Minnesota
Publications - 479
Citations - 41016
Timothy J Wilt is an academic researcher from University of Minnesota. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 94, co-authored 457 publications receiving 36650 citations. Previous affiliations of Timothy J Wilt include Cochrane Collaboration & Agency for Healthcare Research and Quality.
Papers
More filters
Table 1, Pharmacologic treatments for Restless Legs Syndrome
Timothy J Wilt,Roderick MacDonald,Jeannine Ouellette,James Tacklind,Imran Khawaja,Indulis Rutks,Mary Butler,Howard A Fink +7 more
Journal Article
Fecal Microbiota Transplantation for Clostridium difficile Infection
Dimitri Drekonja,Jon Reich,Selome Gezahegn,Nancy Greer,Aasma Shaukat,Roderick MacDonald,Indy Rutks,Timothy J Wilt +7 more
TL;DR: Fecal microbiota transplantation (FMT) is an emerging new therapy for Clostridium difficile infection (CDI) as mentioned in this paper, and a systematic review assessed the efficacy, comparative effectiveness, and harms of FM.
Journal ArticleDOI
Pnflba-11 radical prostatectomy versus observation for early prostate cancer: follow-up results of the prostate cancer intervention versus observation trial (pivot)
Timothy J Wilt,Karen Jones,Michael J. Barry,Gerald L. Andriole,Daniel J. Culkin,Thomas M. Wheeler,William J. Aronson,Michael K. Brawer +7 more
TL;DR: Immediate post TURBT intravesical instillation of G was safe, well tolerated and significantly reduced recurrence of LG NMI UC in these participants.
Journal ArticleDOI
Nutrition as prevention for improved cancer health outcomes: a systematic literature review
Helen Parsons,Mary L Forte,Hamdi Abdi,Sallee A. Brandt,Amy Claussen,Timothy J Wilt,Mark Klein,Elizabeth C. Ester,Adrienne Landsteiner,Joanne L. Slavin,Catherine Sowerby,Wei Xin. Ng,Megan M. Butler +12 more
TL;DR: In this article , a systematic review examined the evidence for the effectiveness of providing nutrition interventions before or during cancer therapy to improve outcomes of cancer treatment and identified randomized controlled trials enrolling at least 50 participants published from 2000 through July 2022.
Journal ArticleDOI
COVID-19 postacute care major organ damage: a systematic review
Nancy Greer,Brad Bart,Charles J. Billington,Susan J. Diem,Kristine E. Ensrud,Anjum S. Kaka,Mark Klein,Anne C. Melzer,Scott Reule,Aasma Shaukat,Kerry M. Sheets,Jamie Starks,Orly Vardeny,Lauren McKenzie,Benjamin Stroebel,Roderick MacDonald,Katie Sowerby,Wei Duan-Porter,Timothy J Wilt +18 more
TL;DR: While the magnitude of effect differed across studies, incident cardiac, pulmonary, liver, acute and chronic kidney, stroke, diabetes, and coagulation disorders were consistently greater in adults hospitalised for COVID-19 compared with non-CO VID-19 controls.